Desoxypipradrol Dosage Guide

overdose of desoxypipradrol can potentially lead to psychosis more readily than the vast majority of stimulants. Psychotic symptoms from desoxypipradrol can include hearing voices, visual hallucinations, urges to harm oneself, severe anxiety, mania, grandiosity, paranoid delusions, confusion, increased aggression, and irritability. - MDMA** - The neurotoxic effects of MDMA may be increased when combined with other stimulants. - Cocaine** - This combination may increase strain on the heart. - **China:** As of October 2015, 2-DPMP is a controlled substance in China. - **Germany:** Desoxypipradrol is controlled under Anlage II BtMG (*Narcotics Act, Schedule II*) as of December 13, 2014. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license. - **Russia:** Deoxypipradol is entered in the Schedule I prohibited substance as (Пиперидин-2-ил)дифенилметан. - **Switzerland:** Desoxypipradol is not controlled under Buchstabe A, B, C and D. It could be considered legal. - **United Kingdom:** As of November 4, 2010, the UK Home Office announced a ban on the importation of 2-DPMP, following a recommendation from the ACMD. Prior to the import ban, desoxypipradrol was sold as a 'legal high' in several products. Its use lead to several Emergency Department visits which prompted the UK government to commission a review from the ACMD. The Advisory Council on the Misuse of Drugs stated in their report that: "*there are serious harms associated with 2-DPMP... typically prolonged agitation (lasting up to 5 days after drug use which is sometimes severe, requiring physical restraint), paranoia, hallucinations and myoclonus (muscle spasms/twitches).*" 2-DPMP was due to become a class B drug on March 28, 2012, but the bill was scrapped as two steroids deemed not to be abusable were included in the bill but were later recommended to remain uncontrolled. There was a new discussion about its fate on April 23, 2012, w